title: Cholinergic modulation of the cortical neuronal network.
abstract: Acetylcholine (ACh) is an important neurotransmitter of the CNS that binds both nicotinic and muscarinic receptors to exert its action. However, the mechanisms underlying the effects of cholinergic receptors have still not been completely elucidated. Central cholinergic neurons, mainly located in basal forebrain, send their projections to different structures including the cortex. The cortical innervation is diffuse and roughly topographic, which has prompted some authors to suspect a modulating role of ACh on the activity of the cortical network rather than a direct synaptic role. The cholinergic system is implicated in functional, behavioural and pathological states including cognitive function, nicotine addiction, Alzheimer's disease, Tourette's syndrome, epilepsies and schizophrenia. As these processes depend on the activation of glutamatergic and GABAergic systems, the cholinergic terminals must exert their effects via the modulation of excitatory and/or inhibitory neurotransmission. However, the understanding of cholinergic modulation is complex because it is the result of a mixture of positive and negative modulation, implying that there are various types, or even subtypes, of cholinergic receptors. In this review, we summarize the current knowledge on central cholinergic systems (projections and receptors) and then aim to focus on the implications for ACh in the modulation of cortical neuronal activity.
authors.affiliation: Laboratoire de Neurobiologie Cellulaire et Moléculaire, INAF-CNRS, 1 avenue de la Terrasse, 91198 Gif-sur-Yvette cedex, France. estelle@nbcm.cnrs-gif.fr
authors.forename: E
authors.initials: E
authors.lastname: Lucas-Meunier
authors.forename: P
authors.initials: P
authors.lastname: Fossier
authors.forename: G
authors.initials: G
authors.lastname: Baux
authors.forename: M
authors.initials: M
authors.lastname: Amar
mesh_terms: D000109:Acetylcholine / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D018678:Cholinergic Agents / Q000494:pharmacology; D002799:Cholinergic Fibers / Q000502:physiology*; D003071:Cognition / Q000502:physiology; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D018079:Receptors, GABA / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D011978:Receptors, Nicotinic / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology
chemical_list: D018678:Cholinergic Agents; D007473:Ion Channels; D018079:Receptors, GABA; D011976:Receptors, Muscarinic; D011978:Receptors, Nicotinic; D000109:Acetylcholine; D002118:Calcium